Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
May 9, 2023Retrospective cohort study presented at ISPOR analyzed real-world data of users and non-users of a digital health solution NEW YORK, May 9, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO)...
- May 4, 2023
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital health market, today announced that it would release its financial results for the first quarter ended March 31, 2023, on Thursday,...
- May 2, 2023
Newly designated convertible preferred stock priced at the market under Nasdaq rules with significant participation by select members of leadership, the Board and existing investors Company also...
- Apr 4, 2023
Dario also appoints digital veteran, Arnaud Robert, to the role of Strategic Advisor to the Chief Executive Officer The appointments strengthen Dario's ability to scale its digital therapeutics...
- Mar 27, 2023
New agreement is the first contract resulting from strategic partnership with Sanofi NEW YORK, March 27, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader...
- Mar 22, 2023
New agreement integrates Dario's cardiometabolic suite into Amwell's market leading digital care delivery enablement platform covering over 90 million lives NEW YORK, March 22, 2023 /PRNewswire/...
- Mar 14, 2023
Dario's musculoskeletal solution uses data from a biofeedback sensor to drive healthier behaviors and reduce pain NEW YORK, March 14, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO)(the...
- Mar 9, 2023
Continued to improve the financial profile of the Company Full-year 2022 revenue of $27.7 million increased 34.8% over $20.5 million in 2021, as B2B revenue growth more than offset managed...
- Mar 2, 2023
DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the fourth quarter and year ended December...
- Feb 27, 2023
Dario demonstrates the impact of targeted coaching interventions in a digital-first chronic care solution Dario solution demonstrates significant impact on hypoglycemic events in senior...
- Feb 24, 2023
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced that management will participate in the Cowen 43nd Annual Healthcare Conference, which...
- Feb 23, 2023
Mr. Kaplan brings a wealth of experience in business strategy specifically in healthcare and digital health NEW YORK, Feb. 23, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) (the...
- Feb 8, 2023
New integration will improve access to Dario's multi-chronic platform for more people living with diabetes NEW YORK, Feb. 8, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) (the "Company"),...
- Feb 6, 2023
Preliminary Results demonstrate success in B2C to B2B transformation Total revenue for the year is expected to be $27.5 million compared to $20.5 million in 2021. B2B expected to represent...
- Jan 24, 2023
Matt Alberico joins Dario to help manage expanding growth opportunities after successfully driving customer growth at Amazon Care, Cigna and Aetna NEW YORK, Jan. 24, 2023 /PRNewswire/ --...
- Jan 9, 2023
DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital therapeutics (DTx) market, announced today the publication of new research in the peer-reviewed journal...
- Jan 3, 2023
Northeast supermarket chain will deploy Dario's cardiometabolic suite in 2023 NEW YORK, Jan. 3, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the...
- Dec 22, 2022
Dario Move to be deployed in Greece and Cyprus to help improve the musculoskeletal health of the general populations New York, Dec. 22, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the...
- Dec 19, 2022
DarioHealth Corp. (NASDAQ: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced the publication of a new study in the peer-reviewed journal Frontiers in...
- Dec 1, 2022
The new accounts originated through an existing relationship with a benefits brokerage and provide further validation of Dario's partnership Strategy. NEW YORK, Dec. 1, 2022 /PRNewswire/ --...
- Nov 16, 2022
DarioHealth Corp. (Nasdaq: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced today that management will participate at the following conferences: 13th...
- Nov 14, 2022
Third quarter 2022 revenues of $6.6 million increased 17.3% from $5.6 million in the third quarter of 2021 driven by growth in Business-to-Business (B2B) revenues. Nine-month year to date revenue...
- Nov 9, 2022
DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the third quarter ended September 30, 2022,...
- Oct 20, 2022
New 'jumbo' employer account represents increasing penetration of the Dario platform NEW YORK, Oct. 20, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader...
-
Oct 13, 2022
Dario to support City employees with integrated solutions addressing diabetes, hypertension, weight management, musculoskeletal and behavioral health in company's first government contract win NEW...
Sep 22, 2022New research sheds light on the importance of training to drive healthier posture NEW YORK, Sept. 22, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital...
- Sep 20, 2022
New accounts demonstrate continued demand for integrated and holistic digital chronic condition management solutions NEW YORK, Sept. 20, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the...
- Aug 15, 2022
Q2 revenue of 6.2 million, a 17.5% increase from the $5.3 million of the second quarter of 2021. Six-month year-to-date revenue totaled $14.2 million, a 60.8% increase over the first six months of...
- Aug 12, 2022
The research examines Dario's ability to improve the health of members in rural areas compared to their urban counterparts and found the solution to be equally effective NEW YORK, Aug. 12, 2022...
- Aug 11, 2022
Dario's digital behavioral health solution will help to improve access and navigation across mental health resources NEW YORK, Aug. 11, 2022 /PRNewswire/ -- DarioHealth Corp. ("Dario",...
- Aug 10, 2022
DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the second quarter ended June 30, 2022, on...
- Aug 4, 2022
The studies underscore the value of Dario's integrated behavioral health solution to help more people connect to effective care that is right for their needs NEW YORK, Aug. 4, 2022 /PRNewswire/ --...
- Jul 21, 2022
Demand for Dario's single approach to chronic condition management continues to show strong demand NEW YORK, July 21, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global...
- Jun 21, 2022
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced a new contract to deliver its digital behavioral health solution for a leading provider...
- Jun 9, 2022
Investment from Elite Healthcare Fund Provides Validation, Access to Capital and Significant Runway to Execute on Strategic Operating Plan NEW YORK, June 9, 2022 /PRNewswire/ -- DarioHealth Corp....
- Jun 3, 2022
The studies demonstrated significant improvement in glucose control and reductions in blood pressure for users managing diabetes and hypertension and improvement in clinical measures for users...
- May 19, 2022
Two new B2B contracts reinforce Dario's position as an emerging leader in multi-chronic digital health NEW YORK, May 19, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in the...
- May 12, 2022
Total Q1 revenue of $8.06 million increased 124% over the comparable prior year period and 34% sequentially over Q4 2021 Accelerated Business-to-Business (B2B) transformation with 14 new B2B...
- May 4, 2022
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the first quarter ended March 31, 2022 on...
- Apr 27, 2022
New research offers fresh evidence that a single digital therapeutics platform can improve outcomes for commonly co-occurring conditions NEW YORK, April 27, 2022 /PRNewswire/ -- DarioHealth Corp....
- Apr 14, 2022
New health plan partnership improves access to digital health for historically underserved populations NEW YORK, April 14, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the...
- Mar 23, 2022Dario continues rapid expansion of employer business across multi-condition suite of solutions
DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, announced today two new employer agreements: first, with a U.S. based social platform employer and...
- Mar 22, 2022Transformational year delivered strong revenue growth of 190% quarter-over-quarter and 171% full year-over-full year
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today reported financial results for the fourth quarter and full year 2021 and provided a corporate and...
- Mar 14, 2022Company to host conference call and webcast on Tuesday, March 22, at 8:30 am ET
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the fourth quarter and full year ended...
- Mar 9, 2022New clients continue Dario's track record of success in winning employer and provider business
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today new agreements with a regional employer and a regional provider. The contracts are...
- Mar 7, 2022
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced that management will participate in the Cowen 42nd Annual Healthcare Conference, which...
-
Mar 1, 2022Novel Strategic Agreement Focuses on Commercial Growth for Dario and the Development of Digital Health Solutions on Dario's Platform
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced it has entered into a strategic agreement with Sanofi U.S., an innovative global healthcare...
- Mar 1, 2022
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that on February 28, 2022 it entered into definitive agreements with institutional...
- Feb 9, 2022New peer-reviewed study sheds light on the effectiveness of an integrated approach for Dario users with both diabetes and high blood pressure.
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced the publication of a retrospective, real-world study demonstrating the impact of managing...
- Feb 8, 2022New contracts expand Dario's footprint to more than 40 clients in the employer market
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced several new contracts to deliver its digital therapeutics solutions for four new...
-
Jan 20, 2022Dario's third all-equity acquisition in the last 12 months brings cutting edge vision technology to the company's comprehensive digital therapeutics platform
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market (the Company), announced it has entered into an agreement to purchase all of the right, title and...
- Jan 19, 2022New Partnership Expands Dario's Payer Presence with First Contract for Managed Medicaid
DarioHealth Corp. (NASDAQ-CM: DRIO), a leader in the global digital therapeutics (DTx) market, announced today it has contracted with a large regional health plan (the "Plan") to deliver its...
- Jan 18, 2022Webinar to be held Wednesday, January 19th at 8am ET
DarioHealth Corp. (Nasdaq: DRIO) a leader in the global digital therapeutics (DTx) market, today announced that it will host an investor webinar on navigating the emerging digital health trends in...
Jan 6, 2022Dario's new employer clients include a contract for its full suite of digital therapeutic solutionsDarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced two new contracts today to provide its highly personalized digital therapeutics beginning in...
-
Dec 21, 2021Dario solutions being offered as part of new premier benefits product designed for small business market
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced a new strategic partnership with a leading employer benefits brokerage (the "Partner") to sell...
- Dec 2, 2021Dario now counts more than 50 clients across multi-chronic condition platform solutions
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced new contracts today to provide its highly personalized digital therapeutics beginning in the...
- Nov 18, 2021Dario now counts 49 clients across multi-chronic condition platform solutions to date as demand continues to grow
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has contracted with two employers to provide its highly personalized digital...
- Nov 15, 2021Strong B2B new contract growth results in total of 47 signed accounts - 85% achieved in the last two quarters
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the third quarter of 2021 and provided a corporate and commercial...
- Nov 15, 2021Newly created role will support the accelerating growth of Dario as a leader in the digital therapeutics market
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the Company appointed Jerrod Helms to the newly created role of Chief Commercial Officer...
- Nov 11, 2021Dario Now Claims 20 New Contracts in the Last Six Months
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has contracted with two new employers and a new provider partner channel to...
- Nov 8, 2021Company to host conference call and webcast on Tuesday, November 16, at 8:30 am ET
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the third quarter ended September 30, 2021 on...
- Nov 5, 2021
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that management will participate at the following conferences: Credit Suisse 30th Annual...
- Nov 3, 2021New partnership makes Dario's full suite of digital therapeutics available to National Group Benefits Platform's large population of employers
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today a new strategic partnership with a leading national benefits administrative platform...
- Nov 1, 2021Dario Expands Provider Footprint to Georgia and Hawaii
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into contracts with two prominent regional providers in Hawaii and...
- Oct 27, 2021Virgin Pulse clients can expand their Homebase for Health® with multi-condition digital therapeutic and health solutions through DarioHealth
DarioHealth today announced it has partnered with Virgin Pulse, the leading global provider of digital and live health and wellbeing solutions, making its next-gen digital therapeutic and health...
- Oct 25, 2021Dario Achieves a Significant Milestone with First Contract for Full Suite of Solutions
DarioHealth Corp. ("Dario," "DarioHealth" or the "Company") (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into a contract with a...
- Oct 18, 2021- New Product Significantly Expands Impact and Value of Dario's Integrated Digital Therapeutics Platform
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today the launch of Dario Move, a new digital physical therapy solution to manage common...
- Oct 14, 2021New Contract Integrates Dario in Health Plan's Behavioral Health Product Serving Millions of Members
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today it has entered into an agreement with one of the largest U.S. national health plans...
- Oct 7, 2021Signals Increasing Demand in the Employer Market for Integrated Chronic Condition Management Solutions
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today an agreement with a global company based in the United States ("Company") to provide its...
- Sep 24, 2021
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that management will participate in a fireside chat during the Cantor Fitzgerald Virtual...
- Sep 17, 2021Dr. Manejwala to Discuss the Application of Digital Innovations in Medicaid Populations
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the company's Chief Medical Officer, Dr. Omar Manejwala, will present at the annual...
- Sep 9, 2021
Dario Continues to Expand its Employer Contracts Across Broad Range of Solutions NEW YORK, Sept. 9, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital...
-
Sep 8, 2021Dario Continues Strong Expansion in Employer Market Leveraging Broad Product Platform
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into an agreement to provide its digital behavioral health platform...
- Aug 31, 2021Dario Continues Strong Expansion in Provider Market Leveraging Broad Product Platform
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has been selected by regional primary care provider PeopleOne Health to be the...
- Aug 16, 2021Total Q2 revenue of $5.3 million increased 46% sequentially and 194% year-over-year
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the second quarter of 2021 and provided a corporate and commercial...
- Aug 12, 2021New Study Presented at American Association of Diabetes Care and Education Specialists Annual Conference Highlights the Clinical Strength of Dario's AI-Driven Journey Engine
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced a new study at the American Association of Diabetes Care and Education Specialists (ADCES)...
-
Aug 9, 2021Company to host conference call and webcast 8:30 am ET
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the second quarter ended June 30, 2021 on Monday,...
- Aug 4, 2021Contract adds to significant growth in the employer market for new behavioral health solution
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it has been selected as the digital behavioral health provider by a leading national...
- Jul 27, 2021New Relationship Expands Dario's Global Reach Across Full Suite of Digital Health Solutions
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, today announced the launch of its digital behavioral health solution that now includes Workplace Options...
- Jul 20, 2021Nationally recognized Primary Care Medical Home becomes latest provider to join growing Dario RPM business
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it has been selected as a digital health provider by Alabama Regional Medical Services...
- Jul 13, 2021Conference brings together leaders in digital therapeutics to share learnings and promote the success of innovative technology
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced Chief Medical Officer Omar Manejwala, M.D. will present "Rebalancing: Digital Therapeutics in...
- Jul 12, 2021Demonstrates robust demand in the employer market
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced the launch of three new employer client contracts, including one global partnership, for...
- Jun 29, 2021New study presented at the American Diabetes Association 81st Scientific Sessions
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, presented new clinical research today at the American Diabetes Association (ADA) 81st Scientific...
- Jun 24, 2021Selection follows thorough evaluation of multiple competitive offerings
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it has been selected as digital health provider by Coastal Family Health Center, a local,...
- Jun 16, 2021New biofeedback sensor improves access to back health solutions and is aimed at increasing membership on Dario's integrated personalization platform
DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, announced today the launch of the Upright GO S, a new wearable sensor based on the company's pioneering...
- Jun 15, 2021
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it is set to join the broad-market Russell 3000® Index and the small-cap Russell 2000®...
- Jun 8, 2021
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, today announced the consummation of the previously announced acquisition of PsyInnovations, Inc. (dba...
- Jun 4, 2021
Study results to be presented at the 14th International Conference on Advanced Technologies and Treatments for Diabetes NEW YORK, June 4, 2021 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a...
- Jun 3, 2021
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the company plans to participate in the upcoming Stifel 2021 Virtual Cross Sector...
- May 27, 2021New Results Further confirm the Relationship Between Personalization and Outcomes
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced the publication of a new study through a Letter to the Editor in the Journal of Diabetes...
- May 26, 2021DarioHealth to Participate in the Virtual 18th Annual Craig-Hallum Institutional Investor Conference
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that management will participate in the 18th Annual Craig-Hallum Institutional Investor...
- May 18, 2021Expands Digital Chronic Care Platform to One of the Most Complete in the Industry
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it has entered into an agreement to acquire PsyInnovations, Inc. (dba wayForward), a...
- May 17, 2021Maintained momentum across all three pillars of long term strategic operating plan
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the first quarter of 2021 and provided a corporate and commercial...
- May 10, 2021Results will be published after market close
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the first quarter ended March 31, 2021 on Monday,...
- May 6, 2021Rick Anderson to Discuss the Role of Digital Health to Manage Chronic Diseases Alongside Global Luminaries Gathered to Explore the Latest Breakthroughs in Medicine, Health Care and Prevention
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that Rick Anderson, President and General Manager of North America, will participate in...
- Apr 20, 2021DarioHealth will Provide Remote Patient Monitoring Services to MediOrbis for New Offering to Medicare Patients with Diabetes
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced today the launch of a new virtual care initiative with MediOrbis, a telehealth provider...
- Mar 9, 2021Significant progress across all pillars of long term strategic operating plan
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the fourth quarter and full year 2020 and provided a corporate and...
- Mar 5, 2021
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the company will participate in the upcoming Stephens 2021 Best Ideas Conference...
- Mar 2, 2021Clinical Study Shows Increased Digital Engagement Resulted in 43% Improvement in Blood Glucose Levels
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, today announced the results of a new clinical study that have been published in the Journal of Medical...
-
Mar 1, 2021Company to host conference call and webcast 8:30 am ET
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the fourth quarter and full year ended December...